In cells treated with BPS, gene sets enriched included Humoral Immunity in Vitiligo, Natural Killer T-Cell Roles in Diabetes Mellitus Type 1, and IL15R triggering NF-kB/NFATC Signaling among others. This evidence concerns the gene NFKB1 and type 1 diabetes mellitus.